.Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02C_AntiadrenalPreparations.H02CA04_Levoketoconazole.Levoketoconazole .Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02C_AntiadrenalPreparations.H02CA04_Levoketoconazole.Levoketoconazole| name: | Levoketoconazole |
| ATC code: | H02CA04 | route: | oral |
| n-compartments | 1 |
Levoketoconazole is the 2S,4R enantiomer of ketoconazole and is used as a cortisol synthesis inhibitor for the treatment of endogenous Cushing’s syndrome in adults. It is an orally active drug and was granted FDA approval in 2021 for this indication.
Pharmacokinetic parameters in adult patients with Cushing’s syndrome; typical demographic data not restricted by age or sex.